References

Gisondi P, Bellinato F, Girolomoni G Topographic differential diagnosis of chronic plaque psoriasis: Challenges and tricks. Journal of Clinical Medicine. 2020; 9:(11) https://doi.org/10.3390/jcm9113594

Palmoplantar psoriasis. 2023. https://www.ncbi.nlm.nih.gov/books/NBK448142/

National Institute for Health and Care Excellence. Tacrolimus and pimecrolimus for atopic eczema. 2004. https://www.nice.org.uk/guidance/ta82/chapter/3-The-technologies

National Institute for Health and Care Excellence. 2017. https://tinyurl.com/5n6fhpk5

National Institute for Health and Care Excellence. Clinical Knowledge Summaries. 2023. https://cks.nice.org.uk/topics/psoriasis

Pelet Del Toro N, Wu JJ, Han G New treatments for psoriasis: An update on the therapeutic frontier. Cutis. 2023; 111:(2)202-104 https://doi.org/10.12788/cutis.0701

Primary Care Dermatology Society. 2021. https://www.pcds.org.uk/clinical-guidance/guttate-psoriasis

Raharia A, Mahil SK, Barker JN Psoriasis: a brief overview. Clin Med (London). 2021; 21:(3)170-173 https://doi.org/10.7861/clinmed.2021-0257

Rendon A, Schakel K Psoriasis pathogenesis and treatment. International Journal of Molecular Science. 2019; 20:(6) https://doi.org/10.3390/ijms20061475

Takeshita J, Grewal S, Langan SM Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017; 76:(3)377-390 https://doi.org/10.1016/j.jaad.2016.07.064

Thaci D, de la Cueva P, Pink AE General practice recommendations for the topical treatment of psoriasis: a modified Delphi approach. BJGP Open. 2020; 4:(5) https://doi.org/10.3399/bjgpopen20X101108

Weigle N, McBane S Psoriasis. Am Fam Physician. 2013; 87:(9)626-633 https://www.aafp.org/pubs/afp/issues/2013/0501/p626.html

Yin X, Low HQ, Wang L Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015; 6 https://doi.org/10.1038/ncomms7916

Psoriasis: an overview

13 August 2024
Volume 33 · Issue 15

Abstract

This article discusses psoriasis with a brief overview of the various types. It considers the symptoms, aetiology and treatment options and hopes to give nurses and non-medical prescribers more confidence in recognising and treating this disease.

Psoriasis is defined as a systemic, immune-mediated inflammatory skin disease, which typically follows a chronic relapsing course (National Institute for Health and Care Excellence (NICE), 2017). The long-term nature of the condition can be very distressing for affected patients, impacting on quality of life. Psoriasis can develop at any age, affecting males and females equally, but is rare in children, and most cases present before the age of 35 years (Knott, 2021). There are several types of psoriasis, which can affect different sites of the body. Of these, chronic plaque psoriasis is the most common form, accounting for 80–90% of cases (Knott, 2021). Other types are shown in Table 1.

Source: McKechnie, 2023; NICE, 2023

Chronic plaque psoriasis, the most common variant, typically presents with well-demarcated circular to oval bright red/pink lesions (plaques) with an overlying white or silvery scale (Knott, 2021). Lesions often have a paler outer edge. The most frequent symptoms experienced are, according to the World Health Organization (2016):

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content